Daniel D. Burton
Known title: Chief Executive OfficerCIK: 0001780980
Daniel D. Burton's purchase track record
How the stock did after each of Daniel D. Burton's open-market purchases, measured from the purchase date. Several fills within a week count as one purchase.
Purchases measured
5
of 5 since August 9, 2022
Stock higher 6 months later
60%
3 months: 40%
Median 6-month return
+5.5%
3 months: -1.8%
Beat the S&P 500
60%
median +2.2% vs. index
| Purchase | Stock | Amount | 3 months | 6 months | S&P 500, 6 mo. |
|---|---|---|---|---|---|
| 2/27/2024 | HCAT | $205K | -17.8% | -16.9% | +10.8% |
| 5/12/2023 | HCAT | $500K | +24.1% | -35.2% | +7.1% |
| 11/11/2022 | HCAT | $2.00M | +41.3% | +5.5% | +3.3% |
| 9/8/2022 | HCAT | $997K | -1.8% | +12.2% | -2.2% |
| 8/9/2022 | HCAT | $2.05M | -44.6% | +25.2% | +1.0% |
Computed by MarketWall from SEC Form 4 filings and daily closing prices (close on the purchase date to the close about 3 and 6 months later). Companies that have since delisted are not included. Past results, not investment advice.
Associated companies
Transaction History
| HCAT | ▼ Sell | Tax Withholding | 55,715 | $162K | 12/1/2025 | View on chart |
| HCAT | ▼ Sell | Tax Withholding | 8,335 | $28K | 9/2/2025 | View on chart |
| HCAT | ▼ Sell | Tax Withholding | 8,658 | $31K | 6/2/2025 | View on chart |
| HCAT | ▼ Sell | Tax Withholding | 33,677 | $154K | 3/3/2025 | View on chart |
| HCAT | ▲ Buy | Grant | 75,437 | $0 | 2/20/2025 | View on chart |
| HCAT | ▲ Buy | Grant | 296,000 | $0 | 2/20/2025 | View on chart |
| HCAT | ▼ Sell | Tax Withholding | 30,897 | $277K | 12/1/2024 | View on chart |
| HCAT | ▼ Sell | Tax Withholding | 4,174 | $30K | 9/3/2024 | View on chart |
| HCAT | ▼ Sell | Tax Withholding | 4,442 | $29K | 6/3/2024 | View on chart |
| HCAT | ▼ Sell | Tax Withholding | 4,973 | $40K | 3/1/2024 | View on chart |
| HCAT | ▲ Buy | Open Market | 26,200 | $205K | 2/27/2024 | View on chart |
| HCAT | ▲ Buy | Grant | 250,000 | $0 | 2/20/2024 | View on chart |
| HCAT | ▼ Sell | Tax Withholding | 8,478 | $63K | 12/1/2023 | View on chart |
| HCAT | ▼ Sell | Tax Withholding | 7,103 | $84K | 9/1/2023 | View on chart |
| HCAT | ▼ Sell | Tax Withholding | 7,411 | $83K | 6/1/2023 | View on chart |
| HCAT | ▲ Buy | Open Market | 49,050 | $500K | 5/12/2023 | View on chart |
| HCAT | ▼ Sell | Tax Withholding | 7,717 | $110K | 3/1/2023 | View on chart |
| HCAT | ▼ Sell | Tax Withholding | 22,058 | $235K | 12/1/2022 | View on chart |
| HCAT | ▲ Buy | Open Market | 197,078 | $2.0M | 11/11/2022 | View on chart |
| HCAT | ▲ Buy | Open Market | 90,750 | $997K | 9/8/2022 | View on chart |
| HCAT | ▼ Sell | Tax Withholding | 7,362 | $85K | 9/1/2022 | View on chart |
| HCAT | ▲ Buy | Open Market | 176,522 | $2.1M | 8/9/2022 | View on chart |
| HCAT | ▼ Sell | Tax Withholding | 7,104 | $101K | 6/1/2022 | View on chart |
| HCAT | ▼ Sell | Tax Withholding | 258 | $4K | 6/1/2022 | View on chart |
| HCAT | ▲ Buy | Option Exercise | 18,518 | $200K | 5/18/2022 | View on chart |
| HCAT | ▲ Buy | Option Exercise | 71,470 | $772K | 5/18/2022 | View on chart |
| HCAT | ▼ Sell | Tax Withholding | 1,862 | $50K | 3/2/2022 | View on chart |
| HCAT | ▲ Buy | Grant | 3,536 | $0 | 3/1/2022 | View on chart |
| HCAT | ▲ Buy | Grant | 8,385 | $0 | 3/1/2022 | View on chart |
| HCAT | ▼ Sell | Tax Withholding | 11,439 | $305K | 3/1/2022 | View on chart |
| HCAT | ▲ Buy | Grant | 125,000 | $0 | 2/24/2022 | View on chart |
| HCAT | ▲ Buy | Option Exercise | 15,530 | $168K | 12/7/2021 | View on chart |
| HCAT | ▼ Sell | Open Market | 15,530 | $628K | 12/7/2021 | View on chart |
| HCAT | ▲ Buy | Option Exercise | 11,126 | $120K | 12/6/2021 | View on chart |
| HCAT | ▲ Buy | Option Exercise | 5,881 | $93K | 12/6/2021 | View on chart |
| HCAT | ▼ Sell | Open Market | 21,972 | $880K | 12/6/2021 | View on chart |
| HCAT | ▲ Buy | Option Exercise | 21,781 | $235K | 12/3/2021 | View on chart |
| HCAT | ▲ Buy | Option Exercise | 14,431 | $229K | 12/3/2021 | View on chart |
| HCAT | ▼ Sell | Open Market | 25,885 | $1.0M | 12/3/2021 | View on chart |
| HCAT | ▼ Sell | Open Market | 10,127 | $420K | 12/3/2021 | View on chart |
| HCAT | ▼ Sell | Open Market | 200 | $8K | 12/3/2021 | View on chart |
| HCAT | ▼ Sell | Tax Withholding | 4,410 | $185K | 12/2/2021 | View on chart |
| HCAT | ▼ Sell | Open Market | 15,890 | $872K | 9/7/2021 | View on chart |
| HCAT | ▲ Buy | Option Exercise | 10,819 | $171K | 9/7/2021 | View on chart |
| HCAT | ▲ Buy | Option Exercise | 48,437 | $523K | 9/3/2021 | View on chart |
| HCAT | ▲ Buy | Option Exercise | 9,493 | $150K | 9/3/2021 | View on chart |
| HCAT | ▼ Sell | Open Market | 52,730 | $2.9M | 9/3/2021 | View on chart |
| HCAT | ▼ Sell | Open Market | 5,200 | $284K | 9/3/2021 | View on chart |
| HCAT | ▼ Sell | Tax Withholding | 4,304 | $233K | 9/1/2021 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
September 27, 2026
Health Catalyst Included in List of Unprofitable Stocks
Health Catalyst was recently named in a Yahoo Finance article listing unprofitable stocks that may fall short of expectations. The company currently trades near its support level, with an average analyst target of $1.77. This context highlights the ongoing focus on the company's profitability and valuation relative to its peers.
Health Catalyst Included in List of Unprofitable Stocks. Health Catalyst was recently named in a Yahoo Finance article listing unprofitable stocks that may fall short of expectations. The company currently trades near its support level, with an average analyst target of $1.77. This context highlights the ongoing focus on the company's profitability and valuation relative to its peers.